World Osteoporosis Day 20.10.17

October 20th, 2017
|

It’s World Osteoporosis Day today and the Veri-te™ resveratrol team would like to help raise awareness of this valuable day and this condition that affects so many people.

  • Osteoporosis affects 75 million people in Europe, the US and Japan.
  • It is estimated to affect 200 million women.
  • Globally there are >8.9 million fractures a year.
  • 1 in 3 women 50+ experience osteoporotic fractures in their lifetime as will 1 in 5 men over 50 years.
  • Just a 10% loss of bone mass doubles the risk of fracture in the vertebrae and is associated with a 2.5 risk in hip fractures.

These are startling statistics.

The International Osteoporosis Foundation recommend a combination of therapies for treatment and prevention. Among these therapies is nutritional supplementation to support healthy bones.

 

Veri-te™ Resveratrol and Bone Health

If you are thinking of developing a new bone health supplement to meet this market demand you may be interested in the science that is available.

 

 

Two published studies using Veri-te™ resveratrol have shown:

  • A significant increase in bone specific alkaline phosphatse (BAP)1,2
  • A dose-dependent increase in spinal bone mineral density2
  • That resveratrol supplementation may affect bone primarily by stimulating formation or mineralisation2

These results suggest that resveratrol promotes the formation of new bone-forming cells. Therefore, resveratrol supports bone health in a way that complements, rather than duplicates, the actions of Vitamin D and Calcium3 making it a vital addition to bone health products.

Ongoing study

At Newcastle University in Australia Professor Peter Howe is conducting an important study4 at looking at the effects of 2 x 75mg/day Veri-te™ resveratrol supplementation on parameters in bone and cognitive health in 170 post-menopausal women. This study started in June this year and will last 24 months.

To find out more click to download our Veri-te™ Resveratrol Bone Health brochure.

Interested in developing a new Bone Health product with Veri-te™? We’d love to hear from you:

Gene Adamski (US sales)

Clare Panchoo (EMEA)

Luc Gruner (Japan)

Geraldine Blanc (Global sales & ROW)

 

References

  1. Poulsen MM, Ornstrup MJ, Harsløf T, et al. Short-term resveratrol supplementation stimulates serum levels of bone-specific alkaline phosphatase in obese non-diabetic men. J Funct Foods 2014;6:305–310.
  2. Ornstrup MJ, Harsløf T, Kjær TN, et al. Resveratrol increases bone mineral density and bone alkaline phosphatase in obese men: a randomized placebo-controlled trial. J Clin Endocrinol Metab 2014;99(12):4720–4729.
  3. Ornstrup MJ, Harsløf T, Sørensen L, Stenkjær L, Langdahl BL, Pedersen SB. Resveratrol Increases Osteoblast Differentiation In Vitro Independently of Inflammation. Calcif Tissue Int. 2016 Aug;99(2):155-63.
  4. Resveratrol for Healthy Ageing in Women. Universal Trial Number (UTN): U1111-1182-8860. https://www.anzctr.org.au/Trial/ Registration/Trial Review.aspx?id=370696